- Home
- OZ vs SOPH Comparison
OZ vs SOPH Comparison
Compare OZ & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OZ
- SOPH
- Stock Information
- Founded
- OZ 2020
- SOPH 2011
- Country
- OZ United States
- SOPH Switzerland
- Employees
- OZ N/A
- SOPH N/A
- Industry
- OZ
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OZ
- SOPH Health Care
- Exchange
- OZ Nasdaq
- SOPH Nasdaq
- Market Cap
- OZ 271.6M
- SOPH 226.6M
- IPO Year
- OZ N/A
- SOPH 2021
- Fundamental
- Price
- OZ $78.01
- SOPH $3.26
- Analyst Decision
- OZ
- SOPH Strong Buy
- Analyst Count
- OZ 0
- SOPH 3
- Target Price
- OZ N/A
- SOPH $7.00
- AVG Volume (30 Days)
- OZ 5.3K
- SOPH 21.3K
- Earning Date
- OZ 01-01-0001
- SOPH 11-05-2024
- Dividend Yield
- OZ N/A
- SOPH N/A
- EPS Growth
- OZ N/A
- SOPH N/A
- EPS
- OZ N/A
- SOPH N/A
- Revenue
- OZ $2,092,000.00
- SOPH $64,488,000.00
- Revenue This Year
- OZ N/A
- SOPH $7.20
- Revenue Next Year
- OZ N/A
- SOPH $15.71
- P/E Ratio
- OZ N/A
- SOPH N/A
- Revenue Growth
- OZ N/A
- SOPH 9.85
- 52 Week Low
- OZ $42.75
- SOPH $2.70
- 52 Week High
- OZ $80.88
- SOPH $7.37
- Technical
- Relative Strength Index (RSI)
- OZ 65.09
- SOPH 46.64
- Support Level
- OZ $77.93
- SOPH $3.06
- Resistance Level
- OZ $80.88
- SOPH $3.47
- Average True Range (ATR)
- OZ 1.87
- SOPH 0.18
- MACD
- OZ 0.20
- SOPH -0.00
- Stochastic Oscillator
- OZ 82.01
- SOPH 45.45
About OZ Belpointe PREP LLC Units
Belpointe PREP LLC is a qualified opportunity fund. The company's investments consist of properties located in qualified opportunity zones for the development or redevelopment of multifamily, student housing, senior living, healthcare, industrial, self-storage, hospitality, office, mixed-use, data centers, and solar projects located throughout the United States and its territories.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.